EUVIMEDEUVIMED entdecken
Open Access

Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)

Richard P Baum, Peipei Wang, Vivianne Jakobsson, Tianzhi Zhao, Christiane Schuchardt, Pek-Lan Khong, Jingjing Zhang

Theranostics · 2024 · 14 (1) · 133-142

DOI: 10.7150/thno.88619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Richard P Baum und 6 weiteren Autor:innen. Beteiligte Einrichtung: CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany. Hauptthemen laut MEDLINE: Neoplasms, Unknown Primary, Neuroendocrine Tumors, Organometallic Compounds. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National University of Singapore, NUS Theranostics Center of Excellence, NUS School of Medicine Nanomedicine Translational Research Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Unknown PrimaryNeuroendocrine TumorsOrganometallic CompoundsMaleHumansFemalePositron Emission Tomography Computed TomographyRetrospective StudiesRadioisotopesReceptors, SomatostatinOctreotide

Stichwörter der Autor:innen

177Lu90YNETs of unknown primary site (CUP-NETs)efficacypeptide receptor radionuclide therapy (PRRT)somatostatin receptor (SSTR)

Substanzen

RadioisotopesReceptors, SomatostatinOctreotideOrganometallic Compounds

Autor:innen und Institutionen

  • CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.
  • Theranostics Center for Molecular Radiotherapy and Precision Oncology, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.
  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Nuclear Medicine, Peking Union Medical College Hospital. Chinese Academy of Medical Science and Peking Union Medical College, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear M…
  • Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Förderung

  • National University of Singapore
  • NUS Theranostics Center of Excellence
  • NUS School of Medicine Nanomedicine Translational Research Programme
  • National Medical Research Counci
  • NMRC Centre Grant Programme

Zitieren

APA

Baum, R. P., Wang, P., Jakobsson, V., Zhao, T., Schuchardt, C., Khong, P. L., & Zhang, J. (2024). Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs). Theranostics, 14(1), 133-142. https://doi.org/10.7150/thno.88619

Vancouver

Baum RP, Wang P, Jakobsson V, Zhao T, Schuchardt C, Khong PL, et al. Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs). Theranostics. 2024;14(1):133-142. doi:10.7150/thno.88619

BibTeX
@article{Baum2024,
  author = {Baum, Richard P and Wang, Peipei and Jakobsson, Vivianne and Zhao, Tianzhi and Schuchardt, Christiane and Khong, Pek-Lan and Zhang, Jingjing},
  title = {Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs)},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {133--142},
  doi = {10.7150/thno.88619}
}
Kostenlos starten →